Stockysis Logo
  • Login
  • Register
Back to News

Dr Reddy's Received Marketing Authorization For Generic Semaglutide Tablets In India For Treatment Of Type 2 Diabetes From Drugs Controller General Of India (DCGI)

Benzinga Newsdesk www.benzinga.com Positive 93.9%
Neg 0% Neu 0% Pos 93.9%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Stockysis © 2026 BISSINT LLC.
Terms of Service Contact Us